Held by the European Society of Cardiology, the meeting features developments in basic science, diagnosis, and management.

For premenopausal women with ER-positive early breast cancer, even if chemotherapy or tamoxifen are given, OFS significantly reduces the 15-year risk of recurrence and death.

In seven patients, there were no signs of toxicity with proton-beam radioablation, clearing the way for future studies.